FDA Authorizes Marketing of ZYN Nicotine Pouches: A New Era for Tobacco Harm Reduction

The U.S. Food and Drug Administration (FDA) has made a significant move in the tobacco harm reduction landscape by authorizing the marketing of 20 ZYN nicotine pouches, marking the first time the agency has approved such products. This decision, announced on Thursday, January 16, 2025, opens the door for Philip Morris International's ZYN to be legally marketed to adults aged 21 and older in the United States.